2024-2025年度家庭常备药上榜品牌揭晓 连花清咳片登榜

Core Viewpoint - Yiling Pharmaceutical's Lianhua Qingke Pian has been awarded as a top brand for household medicines (cough relief and phlegm removal) at the "2024-2025 Annual Household Medicine Top Brand" award ceremony, highlighting its effectiveness in treating respiratory diseases and improving quality of life [1][2] Group 1: Product Efficacy - Lianhua Qingke Pian is guided by traditional Chinese medicine theory and has multiple functions including clearing the lungs, resolving phlegm, and relieving cough, making it widely applicable for various respiratory diseases such as colds, flu, pneumonia, and acute exacerbations of chronic obstructive pulmonary disease [1] - Clinical studies have confirmed that Lianhua Qingke Pian has significant antiviral and antibacterial effects, effectively controlling airway inflammation, reducing cough frequency, shortening cough duration, and improving cough resolution rates [1] - The product also reduces phlegm production, lowers phlegm viscosity, promotes phlegm expulsion, protects airway mucosa, alleviates airway spasms, and improves airway resistance, thereby reducing recurrent airway inflammation and lung damage [1] Group 2: Clinical Research and Recognition - A randomized, double-blind, placebo-controlled, multi-center study involving 480 patients demonstrated that Lianhua Qingke Pian has a rapid cough relief and phlegm resolution effect, with a total clinical efficacy rate of 92.39% and no adverse reactions reported during the study [2] - Due to its proven clinical efficacy and scientific support, Lianhua Qingke Pian has been included over 50 times in national and provincial guidelines, consensus, and treatment plans for respiratory infections, indicating its recognized role in treating cough and phlegm symptoms [2] - The "Household Medicine Top Brand" event has been held for nine years, serving as a trusted reference for families in China, enhancing health management and guiding rational medication use [2]